Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-02-27
1994-01-25
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 530363, 530364, 530362, A61K 3736
Patent
active
052815820
ABSTRACT:
A novel glycosylated form of albumin designated EGA and isolated from biological fluids is further characterized by its cell growth promoting activity. A process of isolation of human or bovine glycosylated albumin is described. The EGA fractions have been identified by serological histochemical and biological assays as well as lectin reactivity. The growth-promoting effect of EGA is directed to various transformed cell lines and primary cells of mammalian origin. Hepatoma cells have been found to produce EGA, in vitro. Novel compositions of EGA containing media are provided for cell, tissue or organ culture.
REFERENCES:
patent: 4963529 (1990-10-01), Fujioka et al.
patent: 5093317 (1992-03-01), Lewis et al.
Peach et al. Biochim. Biophys Acta 1097 1991 49-54.
The Plasma Proteins: Structure, Function, & Genetic Control: 63-70 & 134-141 (1975).
Day, et al. J. Biological Chem. 264: 595-597 (1979).
Dolhofer, et al., FEBS Letters 103: 282-286 (1979).
Williams, et al. PNAS (USA) 78: 2393-2397 (1981).
Shaklai, et al. J. Biological Chem. 259: 3812-3817 (1984).
Rendell, et al. J. Laboratory & Clinical Med. 105: 63-69 (1985).
Iberg, et al. J. Biological Chem. 261: 13542-13545 (1986).
Morris, et al. Biochem. Med. & Metabolic Biology 35: 267-270 (1986).
Simpietro, et al. The Lancet: 994-996 (1987).
Shima, et al. Diabetologia 35: 627-631 (1988).
Ammanannati, et al. Arzneim.-Forsch/Drug Res. 39: 661-664 (1989).
Aring, et al. Biochimica et Biophysica Atca 1010: 140-144 (1989).
Cohen, et al. J. Immunological Methods 117: 121-129 (1989).
Gabius, et al. Histochemistry 91: 5-11 (1989).
Murphy. Int'l J. Cell Cloning 8: 138-145 (1990).
Smith, et al. Pharmaceutical Res. 6: 466-473 (1989).
Svacina, et al. Computer Methods and Programs in Biomedicine 32: 259-263 (1990).
Ahmed, et al. Analyitcal Biochemistry 192: 109-111 (1991).
Peach, et al. Biochimica et Biophysica Acta 1097: 49-54 (1991).
Zaitsu, et al. J. of Cell. Physiology 149: 339-346 (1991).
Alliance Pharmaceuticals Corp.
Schain Howard E.
Touzeau P. Lynn
LandOfFree
Serum growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum growth factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-727700